Arena Pharmaceuticals, Inc.
ARNAN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
5
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ARNA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Etrasimod
Ulcerative Colitis
Etrasimod 1 mg
Atopic Dermatitis
APD356-lorcaserin hydrochloride
Smoking Cessation
Olorinab
Crohn's Disease
APD125
Insomnia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Etrasimod | Phase 3 | Ulcerative Colitis | - | - |
Etrasimod 1 mg | Phase 2 | Atopic Dermatitis | - | - |
APD356-lorcaserin hydrochloride | Phase 2 | Smoking Cessation | - | - |
Olorinab | Phase 2 | Crohn's Disease | - | - |
APD125 | Phase 2 | Insomnia | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply